Last updated 33 days ago
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
586 patients around the world
Available in Argentina, United States, Mexico
Eli Lilly and Company
8Research sites
586Patients around the world
This study is for people with
Obesity
Low Back Pain
Requirements for the patient
From 18 Years
All Gender
Medical requirements
- Have a history of axial-predominant low back pain.Have pain that is restricted to the low back or with a referral pattern limited to the proximal legs.Have a body mass index (BMI) ≥27 kilograms per square meter (kg/m2) at screening.Have a history of at least 1 self-reported unsuccessful dietary effort to lose body weight.
- Have a non-axial origin low back pain.Have had botulinum or steroid injections to the spine within 1 year of screening.Have had trigger point injection to the spine within 6 months of screening.Have a self-reported change in body weight >5 kilograms (kg) (11 pounds) within 90 days prior to screening.Have been taking drugs to promote body weight reduction, including over-the-counter medications, within 90 days prior to screening.Have a prior or planned surgical treatment for obesity.Have Type 1 Diabetes, Type 2 Diabetes, or any other type of diabetes.
Sites
CIPREC Centro de Investigación y Prevención Cardiovascular - CABA
Centro Médico Viamonte SRL - CABA, Buenos Aires
Centro Médico Maffei - CABA, Buenos Aires
Centro de Investigaciones Clínicas Baigorria
Instituto Medico Catamarca "IMEC"
Centro de Diagnóstico y Rehabilitación - CEDIR
Fundación Respirar
Investigaciones Médicas IMOBA SRL
StudyTRIUMPH-7
SponsorEli Lilly and Company
Study typeInterventional
Conditions
ObesityLow Back Pain
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT07035093
